Collaboration is key to success for aerospace in state


February 17, 2011

Nearly 300 professionals from the aerospace and defense industry and from universities throughout the state came together to launch the Aerospace and Defense Research Collaboratory (ADRC), Feb. 11, at Arizona State University’s Polytechnic campus.

The ASU-led ADRC, funded under the Aerospace & Defense Initiative from Science Foundation Arizona, is a state-wide initiative to build broad partnerships between higher education and industry. Download Full Image

In addition to facilitating collaborative research projects involving universities and companies to advance aerospace and defense related technologies, the ADRC is an endeavor that is intended to help create and retain jobs and make Arizona the location of choice for companies seeking greater access to technologies in the aerospace and defense sector.

“The Collaboratory allows us to come together collaboratively to align our missions and leverage all of our expertise and provide coordination to what has been a loose and disconnected network of assets from around the state so that we can all advance,” said Mitzi Montoya, ADRC co-director and executive dean in ASU’s College of Technology and Innovation.

Werner Dahm addressed the changing security threats being faced by the nation and the need to create technology-enabled solutions to address these, as well as to quicken the innovation cycle from research through development to fielding.

“Launching the ADRC is the first step, but an important and substantive one, in building the research base in Arizona to address security,” said Dahm, director of ASU’s new Security and Defense Systems Initiative and former chief scientist of the U.S. Air Force. “Science and technology investment is needed, and this is an opportunity to align ourselves strategically to secure the scarce funding.”

Two separate panel discussions, led by co-directors Montoya and Dahm, focused on the ability for the A&D industry to jumpstart the state’s economy and the role government has in fostering high tech industry growth. The panel discussions included comments from aerospace and defense leaders from around the state.

Some of the key takeaways from the panel discussions were:

• The ADRC is seen as playing a role in advocacy for the industry in the state and having the ability to facilitate collaborations between industry and academia in use-directed research efforts.

• The ADRC will help identify the future direction for where the state needs to be in terms of enabling technology solutions, training and education of future generations, and developing opportunities and new areas of business.

• Government at the state and local levels plays an important role in creating a business climate that supports growth of aerospace and defense industry.

The next meeting of the ADRC will be on March 25 in Tucson where the group will hold strategy sessions, and identify strengths, funding opportunities and ways to match expertise.

To see projects that are currently under way by some of the partners, visit http://adrc.asu.edu/projects.

For">http://adrc.asu.edu/projects">http://adrc.asu.edu/projects.

For information, contact the ADRC at adrc">mailto:adrc@asu.edu">adrc@asu.edu  or visit http://adrc.asu.edu.">http://adrc.asu.edu">http://adrc.asu.edu.

ASU forms innovative international health care partnership


February 17, 2011

Agreement establishes 1st Biosignatures Center between ASU and Taiwan’s Chang Gung University – partnership will improve patient outcomes and reduce costs

ASU and Taiwan’s Chang Gung University (CGU) have formalized an agreement to establish an international Biosignatures Center aimed at the prevention, early detection, diagnosis, and treatment of cancer and other diseases. Download Full Image

ASU’s Nobel laureate, Leland Hartwell, is chief scientist at the Biodesign Institute’s Center for Sustainable Health (CSH) and will co-direct the Chang Gung Biosignatures Center. “The most important thing we can do to improve health care and reduce its costs, is to develop informative tests for prevention, early detection, and effective therapeutic intervention for disease. This collaboration is the most exciting opportunity I have had to achieve these goals,” Hartwell said.

This agreement unites two ambitious research universities that are dedicated to improving health care through a comprehensive interdisciplinary effort that seeks collaborative engagement of key health care stakeholders including: governments, public and private health insurers, research institutes, industry, and innovative health care delivery systems around the world.

The Center for Sustainable Health (CSH) at ASU was founded by Michael Birt, director. CSH will provide expertise, technology platforms, access and informatics support to the Chang Gung Biosignatures Center. It is anticipated that research centers at multiple sites both in Taiwan and internationally will exchange information in a pre-competitive space to improve health outcomes and reduce the human and financial cost of disease.

“In addition to our relationship with Chang Gung University itself, we have been delighted by the response from leading companies in the medical field interested in collaborating with us to provide more innovative solutions to help sustain health,” Birt said.

Last year, the Center for Sustainable Health (CSH) launched the Global Biosignatures Network (GBN) to harness scientific, academic, industry and health care system resources to make a major impact on 21st century health care practice. A global network of Biosignatures Centers also is needed to properly scale the effort, provide rigorous standards of practice needed to overcome barriers, and supply a global platform to share methods, results and experiences. In keeping with CSH’s mission to sustain human health, the GBN will work with forward‐thinking partners to establish additional Biosignatures Centers within member systems. Each Biosignatures Center will serve as a virtual coordinating center to discover, develop, validate and implement diagnostic tests based on new enabling molecular and digital technologies for managing disease with an emphasis on prevention, early detection and effective therapeutic interventions.

Joe Caspermeyer

Managing editor, Biodesign Institute

480-258-8972